Since 1994, alcohol septal ablation (ASA) has been used as a minimally invasive treatment of patients with hypertrophic obstructive cardiomyopathy, resistant to conservative medical therapy. This catheter-based intervention consists of injecting absolute
Sotir Marchev, Boyko Kuzmanov
doaj +6 more sources
Alternative ‘block and delivery’ approach for alcohol septal ablation in hypertrophic cardiomyopathy with ischemia: a case report [PDF]
Background Hypertrophic cardiomyopathy (HCM) is a prevalent hereditary cardiac disorder characterized by marked myocardial hypertrophy, which may lead to impaired diastolic function and relative myocardial ischemia.
S. M. Mamun Iqbal +6 more
doaj +3 more sources
3-Dimensional Multiplanar Reconstruction With Transesophageal Echocardiography for Alcohol Septal Ablation [PDF]
This study described the first experience with 3-dimensional multiplanar reconstruction transesophageal echocardiography to guide percutaneous alcohol septal ablation.
Konstaninos Voudris, MD, PhD +3 more
doaj +3 more sources
Alcohol Septal Ablation or Mavacamten for Obstructive Hypertrophic Cardiomyopathy. [PDF]
Hypertrophic cardiomyopathy (HCM) is a genetic disease characterized by an increased left ventricular wall thickness in the absence of increased afterload conditions. In addition to diastolic dysfunction, obstruction of the left ventricular outflow tract is common in HCM and has an important influence on symptoms and outcome. Over the last five decades
Scholtz S, Rudolph V, Reil JC.
europepmc +5 more sources
Alcohol septal ablation – An evolving procedure
Alcohol septal ablation was first reported by Sigwart in 1985.1 Since then the use of this procedure has increased exponentially and today the number of alcohol ablations performed far exceed that of surgical myectomy.2 Alcohol septal ablation has been reported from Indian centres since the mid-1990s.3 ...
Ajay Bahl
doaj +3 more sources
Contrast echocardiography with a physiological contrast agent for alcohol septal ablation [PDF]
PurposeMyocardial contrast echocardiography in alcohol septal ablation (ASA) is critical prior to alcohol injection into the target septal artery branch.
Erdogan Ilkay +10 more
doaj +2 more sources
Recurrent and Progressive CAVB After Alcohol Septal Ablation for HOCM: Bridging Therapy With a Semi‐Permanent Pacemaker [PDF]
In patients undergoing alcohol septal ablation for hypertrophic obstructive cardiomyopathy, complete atrioventricular block can be delayed and recurrent. A semi‐permanent pacemaker serves as an effective bridging therapy, allowing for extended monitoring
Enyuan Zhang +7 more
doaj +2 more sources
Alcohol septal ablation in hypertrophic cardiomyopathy: For which patients? [PDF]
Percutaneous and surgical therapies for septal reduction for hypertrophic cardiomyopathy have been going head‐to‐head for the past 20 years with similar outcomes and mortality rates, although contemporary myectomy seems to materialize its superiority ...
Alexandru Achim +5 more
doaj +2 more sources
The efficacy and safety of alcohol septal ablation stratified by alcohol dosage for patients with hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis [PDF]
Background Alcohol septal ablation (ASA) is recommended for moderate to severe symptomatic patients with hypertrophic obstructive cardiomyopathy. The current guidelines don not recommend particular alcohol doses and the amount of alcohol injected into ...
Ahmed Elshahat +11 more
doaj +2 more sources
Background: Alcohol septal ablation is recommended for hypertrophic obstructive cardiomyopathy patients who had refractory symptoms despite optimal medical treatment.
Umut Karabulut +5 more
doaj +1 more source

